Cadilap (Lapatinib (250mg))

Cadilap Tablet is a medication that is often prescribed for certain types of cancer. It primarily helps to support patients by targeting specific pathways in cancer cells, which may assist in slowing down the progression of the disease. This can be an important part of a comprehensive treatment plan, helping individuals manage their condition more effectively.

The active ingredient in Cadilap Tablet is Lapatinib. It works by inhibiting certain proteins that are involved in the growth and spread of cancer cells. By blocking these proteins, Lapatinib can contribute to limiting the growth of tumors, providing patients with a potential means to enhance their treatment outcomes.

For optimal use, it is advisable to store Cadilap Tablets in a cool, dry place away from direct sunlight. Consistency in taking the medication is important, and it should be done as directed by a healthcare professional. Patients should be mindful of any other medications they are taking and inform their doctor about their complete medical history to avoid any potential interactions.

Some common side effects that may occur with the use of Cadilap Tablet include nausea, diarrhea, and fatigue. These effects are generally mild but can vary by individual.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.